Victoza® / Saxenda®
Liraglutide
Established GLP-1 option for diabetes and weight care
Liraglutide is an FDA-approved prescription medication for type 2 diabetes and chronic weight management.
About Victoza® / Saxenda®
Liraglutide is available as Victoza® for type 2 diabetes and Saxenda® for chronic weight management. Your CARMA Med Spa clinician evaluates whether this GLP-1 option aligns with your health history and treatment goals.
Key benefits
- Long-established GLP-1 receptor agonist with clinical history
- FDA-approved pathways for diabetes and weight management
- Daily dosing with structured titration schedule
- Supervised by licensed clinicians throughout treatment
Who may qualify
- BMI and comorbidity criteria per FDA labeling for weight use
- Diabetes indication for Victoza® per prescribing guidelines
- Full review of thyroid, renal, and GI history before prescribing
How treatment works
Evaluation visit
Your provider determines whether Victoza® or Saxenda® is clinically appropriate.
Titration schedule
Dosing increases gradually over weeks to improve tolerability.
Long-term support
Ongoing monitoring for weight, glucose, and side-effect management.
Good to know
- Daily injection requires consistent adherence.
- Thyroid C-cell tumor history is a contraindication per labeling.
- Individual results vary; not all patients are candidates.
GLP-1 medications are available by prescription only after a licensed provider determines eligibility. This information is educational and not medical advice.
Common questions
Both contain liraglutide but are FDA-approved for different indications and dosing. Your clinician selects the appropriate product based on your diagnosis and goals.
Yes, though newer weekly options exist. Your provider recommends the best fit based on your medical profile and preferences.
Wegovy
Semaglutide
Prescription weight-loss medication for adults with obesity or excess weight and related health conditions.
Zepbound
Tirzepatide
FDA-approved weight management medication containing tirzepatide for adults with obesity or related health conditions.
Ozempic
Semaglutide
GLP-1 prescription medication FDA-approved for type 2 diabetes and prescribed off-label for weight management.